Craig Wong-Pan
Stock Analyst at RBC Capital
(0.76)
# 3,935
Out of 4,504 analysts
299
Total ratings
44.3%
Success rate
-2.3%
Average return
Main Sectors:
Stocks Rated by Craig Wong-Pan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintained: Buy | $321 → $276 | $203.87 | +35.38% | 35 | Jul 8, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $113.00 → $107.00 | $122.89 | -12.93% | 32 | Jun 15, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $25.00 → $23.00 | $21.24 | +8.29% | 24 | Jun 15, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.75 → $0.72 | $0.715 | +0.70% | 13 | Jun 11, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.20 → $3.05 | $2.06 | +48.06% | 21 | May 28, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Upgraded: Hold | $37.29 → $34.00 | $40.25 | -15.53% | 4 | May 26, 2026 | |
| ASX: REG Regis Healthcare Limited | Upgraded: Buy | $8.00 → $7.50 | $6.32 | +18.67% | 27 | May 25, 2026 | |
| ASX: ALC Alcidion Group Limited | Maintained: Hold | $0.12 → $0.13 | $0.098 | +32.65% | 22 | May 18, 2026 | |
| ASX: HLS Healius Limited | Downgraded: Sell | $0.75 → $0.35 | $0.385 | -9.09% | 29 | May 13, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $297.00 → $125.00 | $121.62 | +2.78% | 20 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 | $16.27 | +10.63% | 5 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36.00 → $45.00 | $41.95 | +7.27% | 21 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.00 → $3.75 | $3.24 | +15.74% | 17 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 | $31.27 | +31.12% | 7 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.80 → $2.40 | $2.22 | +8.11% | 19 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16.04 | $26.37 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31.60 | $13.30 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6.57 | $22.54 | n/a | 1 | May 22, 2019 |
ResMed
Jul 8, 2026
Maintained: Buy
Price Target: $321 → $276
Current: $203.87
Upside: +35.38%
CSL Limited
Jun 15, 2026
Maintained: Hold
Price Target: $113.00 → $107.00
Current: $122.89
Upside: -12.93%
Sonic Healthcare Limited
Jun 15, 2026
Maintained: Hold
Price Target: $25.00 → $23.00
Current: $21.24
Upside: +8.29%
Monash IVF Group Limited
Jun 11, 2026
Maintained: Hold
Price Target: $0.75 → $0.72
Current: $0.715
Upside: +0.70%
Integral Diagnostics Limited
May 28, 2026
Maintained: Buy
Price Target: $3.20 → $3.05
Current: $2.06
Upside: +48.06%
Fisher & Paykel Healthcare Corporation Limited
May 26, 2026
Upgraded: Hold
Price Target: $37.29 → $34.00
Current: $40.25
Upside: -15.53%
Regis Healthcare Limited
May 25, 2026
Upgraded: Buy
Price Target: $8.00 → $7.50
Current: $6.32
Upside: +18.67%
Alcidion Group Limited
May 18, 2026
Maintained: Hold
Price Target: $0.12 → $0.13
Current: $0.098
Upside: +32.65%
Healius Limited
May 13, 2026
Downgraded: Sell
Price Target: $0.75 → $0.35
Current: $0.385
Upside: -9.09%
Cochlear Limited
Apr 22, 2026
Maintained: Buy
Price Target: $297.00 → $125.00
Current: $121.62
Upside: +2.78%
Apr 15, 2026
Maintained: Buy
Price Target: $18.00
Current: $16.27
Upside: +10.63%
Feb 26, 2026
Maintained: Hold
Price Target: $36.00 → $45.00
Current: $41.95
Upside: +7.27%
Feb 24, 2026
Maintained: Hold
Price Target: $4.00 → $3.75
Current: $3.24
Upside: +15.74%
Feb 16, 2026
Maintained: Buy
Price Target: $41.00
Current: $31.27
Upside: +31.12%
Feb 16, 2026
Maintained: Hold
Price Target: $2.80 → $2.40
Current: $2.22
Upside: +8.11%
Oct 6, 2020
Maintained: Sell
Price Target: $16.04
Current: $26.37
Upside: n/a
Oct 6, 2020
Maintained: Buy
Price Target: $31.60
Current: $13.30
Upside: n/a
May 22, 2019
Downgraded: Sell
Price Target: $6.57
Current: $22.54
Upside: n/a